Fund moves
78KShares reported
From a 13F filed Nov 16, 2026 covering holdings at Sep 30, 2026 — a quarter-end snapshot, not a live trade.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Traded Nov 3, 2026 · Filed Nov 4, 2026
Derivative exercise or conversion — not an open-market buy.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
option exercise
Code M — exercise or conversion of a derivative security
Footnote references vesting of compensation awards
Only flagged when a footnote says so; never inferred
Fund moves
From a 13F filed Nov 16, 2026 covering holdings at Sep 30, 2026 — a quarter-end snapshot, not a live trade.
Insider selling
Traded Nov 5 · filed 1 day laterNot reported under a pre-arranged trading plan
A Bristol Myers Squibb director sold $241K of Bristol Myers Squibb shares. The filing does not indicate a pre-arranged trading plan.
Insider selling
Traded Nov 5 · filed the same day
A Bristol Myers Squibb director told the SEC about a plan to sell $250K of Bristol Myers Squibb shares around Nov 5, 2026. The shares were not acquired as compensation.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.